Tyrosine-614, the major autophosphorylation site of the receptor tyrosine kinase HEK2, functions as multi-docking site for SH2-domain mediated interactions

Oncogene

Volumn 17, Issue 2, 1998, Pages 255-260

  Hock, Björn ^a   Böhme, Beatrix ^a   Karn, Thomas ^a   Feller, Stephan ^b   Rübsamen Waigmann, Helga ^c   Strebhardt, Klaus ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b Medizinisches Inst F S   (Germany)

^c BAYER AG   (Germany)

Author keywords

Eph related kinases; HEK2; SH2 domains; Signal transduction

Indexed keywords

BINDING PROTEIN; DOCKING PROTEIN; PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; IMMUNOPRECIPITATION; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0032537766     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1201907     Document Type: Article

References (22)

1. Böhme B, Holtrich U, Wolf G, Luzius H, Grzeschik K-H. Strebhardt K and Rübsamen-Waigmann H. (1993). Oncogene, 8, 2857-2862.
2. Böhme B, VandenBos T, Cerretti DP, Park LS, Holtrich U, Rübsamen-Waigmann H and Strebhardt K. (1996). J. Biol. Chem., 271, 24747 24752.
3. Brambilla R and Klein R. (1995). Mol. Cell. Neurosci., 6, 487 495.
4. Braunger J, Schleithoff L, Schulz AS, Kessler H, Lammers R, Ullrich A, Bartram CR and Janssen JWG. (1997). Oncogene, 14, 2619 2631.
5. Ellis C, Kasmi F, Ganju P, Walls E, Panayotou G and Reith AD. (1996). Oncogene, 12, 1727 1736.
6. Feller SM, Knudsen B and Hanafusa H. (1994). EMBO J., 13, 2341 2351.
7. Feller SM, Knudsen B and Hanafusa H. (1995). Oncogene, 10, 1465 1473.
8. Fox GM. Holst PL, Chute HT, Lindberg RA, Janssen AM, Basu R and Welcher AW. (1995). Oncogene, 10, 897 905.
9. Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, Henkemeyer M, Strebhardt K, Hirai H, Wilkinson DG, Pawson T, Davis S and Yancopoulos GD. (1996). Neuron, 17, 9 19.
10. Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, Pawson T and Klein R. (1996). Cell, 86, 35 46.
11. Hollenberg SM, Sternglanz R, Cheng PF and Weintraub H. (1995). Mol. Cell. Biol., 15, 3813 3822.
12. Hu K-Q and Settleman J. (1997). EMBO J., 16, 473-483.
13. Karn T, Holtrich U, Bräuninger A, Böhme B, Wolf G, Rübsamen-Waigmann H and Strebhardt K. (1993). Oncogene, 8, 3433 3440.
14. Kashishian A, Kazlauskas A and Cooper J. (1992). EMBO J., 11, 1373 1382.
15. Orioli D, Henkemeyer M, Lemke G, Klein R and Pawson T. (1996). EMBO J., 15, 6035-6049.
16. Pandey A, Lazar DF, Saltiel AR and Dixit VM. (1994). J. Biol. Chem., 269, 30154 30157.
17. Pandey A, Duan H and Dixit VM. (1995). J. Biol. Chem., 270, 19201 19204.
18. Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G and Comoglio PM. (1994). Cell, 77, 261 271.
19. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, Neel BG, Birge RB, Fajardo JE, Chou MM, Hanafusa H, Schaffhausen B and Cantley LC. (1993). Cell, 72, 767 778.
20. Stein E, Cerretti DP and Daniel TO. (1996). J. Biol. Chem., 271, 23588 23593.
21. Tuzi NL and Gullick WJ. (1994). Br. J. Cancer, 69, 417 421.
22. Vojtek AB, Hollenberg SM and Cooper JA. (1993). Cell, 74, 205 214.